SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-037559
Filing Date
2024-02-15
Accepted
2024-02-15 16:18:37
Documents
25
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d790577d8k.htm   iXBRL 8-K 45952
2 EX-1.1 d790577dex11.htm EX-1.1 228312
3 EX-4.1 d790577dex41.htm EX-4.1 66985
4 EX-5.1 d790577dex51.htm EX-5.1 59940
5 EX-5.2 d790577dex52.htm EX-5.2 11030
6 EX-99.1 d790577dex991.htm EX-99.1 11501
7 EX-99.2 d790577dex992.htm EX-99.2 11748
12 GRAPHIC g790577g0215131344764.jpg GRAPHIC 1499
13 GRAPHIC g790577g0215131344936.jpg GRAPHIC 4284
14 GRAPHIC g790577g0215131345095.jpg GRAPHIC 5930
15 GRAPHIC g790577g0215131743058.jpg GRAPHIC 1561
  Complete submission text file 0001193125-24-037559.txt   732275

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nams-20240213.xsd EX-101.SCH 4098
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240213_def.xml EX-101.DEF 13741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240213_lab.xml EX-101.LAB 22929
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240213_pre.xml EX-101.PRE 14709
27 EXTRACTED XBRL INSTANCE DOCUMENT d790577d8k_htm.xml XML 6048
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24644054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)